Procurement of lateral flow (LFA) strips for the rapid HIV nucleic acid diagnostic test
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in ATLANTA, GA
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- 75D30126Q79099
- Opportunity Type
- Combined Synopsis/Solicitation
- Sub-Agency
- CENTERS FOR DISEASE CONTROL AND PREVENTION
- Office
- CDC OFFICE OF ACQUISITION SERVICES
- Posted Date
- Friday, July 24, 2026
- Response Deadline
- Wednesday, July 29, 2026
- PSC Code
- AJ11
- Set-Aside
- No Set Aside
- Place of Performance
- ATLANTA, GA, 30333
- Status
- Active
Description
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Requirements (FAR) Subpart 12.202, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested. The solicitation number for this requirement is 75D30126Q79099 and is hereby issued as a Request for Quote (RFQ) using FAR Subpart 12 - Acquisition of Commercial Products and Commercial Services. The Centers for Disease Control and Prevention intends to award a firm-fixed-price contract, see the attached RFQ for more details and instructions to offerors. See the CLINS and FAR Clauses and Provisions associated with this combined synopsis / solicitation in the attached RFQ. Period of P
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in ATLANTA, GA. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
